Brickell Biotech, Inc. (BBI): Price and Financial Metrics

Brickell Biotech, Inc. (BBI): $2.35

0.05 (+2.17%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add BBI to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#126 of 397

in industry

BBI Price/Volume Stats

Current price $2.35 52-week high $37.35
Prev. close $2.30 52-week low $2.21
Day low $2.21 Volume 31,300
Day high $2.37 Avg. volume 206,730
50-day MA $3.42 Dividend yield N/A
200-day MA $8.77 Market Cap 6.75M

BBI Stock Price Chart Interactive Chart >


Brickell Biotech, Inc. (BBI) Company Bio


Brickell Biotech, Inc., a clinical-stage pharmaceutical company, focuses on identifying, developing, and commercializing various prescription therapeutics for the treatment of debilitating skin diseases in the United States. The company's lead product candidate is sofpironium bromide that is in phase 3 clinical trial to treat patients with primary axillary hyperhidrosis. Its pipeline consists of potential novel therapeutics for hyperhidrosis and other prevalent dermatological conditions. Brickell Biotech, Inc. has a collaboration agreement with AnGes, Inc. for the development of a novel DNA vaccine candidate for COVID-19. The company was founded in 2009 and is headquartered in Boulder, Colorado.


BBI Latest News Stream


Event/Time News Detail
Loading, please wait...

BBI Latest Social Stream


Loading social stream, please wait...

View Full BBI Social Stream

BBI Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -84.03%
5-year -97.51%
YTD N/A
2023 N/A
2022 0.00%
2021 -70.67%
2020 -47.97%
2019 -81.84%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!